Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Robert M. Prins, PhD

Member Researcher

Biography

Robert Prins, PhD, is an immunologist by training, with a broad background in solid tumors and specific training and expertise in brain tumor immunotherapy. At the University of California, Los Angeles, he is currently the principal investigator or a co-investigator on several extramural-funded grants that are testing novel immunotherapeutic regimens in preclinical models and malignant glioma patients.

He is also the co–principal investigator on an NCI Brain SPORE and an NINDS resident research training grant and is a member of the Parker Institute for Cancer Immunotherapy. He is the director of a resident research committee and of the I3T Seminar Series at UCLA, as well as a supervisor to several graduate students, medical students, hematology/oncology Fellows, and neurosurgery residents.

Dr. Prins currently leads three different investigational immunotherapy clinical trials at UCLA for glioma patients, and he pioneered the development of personalized dendritic cell vaccines for malignant glioma.

Education & Training

  • 1992: UCLA, Los Angeles, CA, B.S., Kinesiology
  • 1996: UCLA, Los Angeles, CA, M.S., Physiological Science
  • 2001: Virginia Commonwealth University/Medical College of Virginia, Richmond, VA, Ph.D., Anatomy and Immunology
  • 2001: Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, CA, Postdoctoral Fellowship
  • 2002: UCLA, Los Angeles, CA, Postdoctoral Fellowship, Department of Neurosurgery

Awards & Honors

  • 2000: Phi Kappa Phi Award; Virginia Commonwealth University, Medical College of Virginia
  • 2000: C.C Clayton Award, Virginia Commonwealth University, Medical College of Virginia
  • 2001: Jack Denning Burke Award; VCU/MCV Department of Anatomy Outstanding Graduate Student in Cell Biology
  • 2001: Osterud Award; VCU/MCV Department of Anatomy Outstanding Graduate Student
  • 2002: Co-PI, Grant from Northwest Biotherapeutics. Treatment of CNS gliomas with intracranial IFN-? and dendritic cells pulsed with allogeneic peptides.
  • 2002: UCLA Tumor Immunology Training fellowship (5-T32-CA09120-28).
  • 2002: Fellowship, Norman Cousins Center for Psychoneuroimmunology.
  • 2005: Fellowship, NCI Cancer Education Grant, R25 CA 098010, Scholars in Oncologic Molecular Imaging (SOMI)
  • 2005-06: UCLA Chancellor’s Professional Development award
  • 2006-11: K01 CA111402 Howard Temin Research Scientist Development Award
  • 2008-11: STOP CANCER Research Career Development Award
  • 2008-09: UCLA Jonsson Comprehensive Cancer Center Collaborative grant award